SBIR-STTR Award

Artificial Intelligence-augmented Raman scanner small and portable for the warfighter to detect, identify and differentiate pathogens
Award last edited on: 9/12/22

Sponsored Program
SBIR
Awarding Agency
DOD : AF
Total Award Amount
$49,648
Award Phase
1
Solicitation Topic Code
AF211-CSO1
Principal Investigator
Benjamin Harvey

Company Information

Adolphe Group LLC (AKA: The Adolphe Group LLC~Forward Edge AI, Inc)

10108 Carter Cyn
San Antonio, TX 78255
   (703) 999-7583
   N/A
   www.forwardedge-ai.com
Location: Single
Congr. District: 23
County: Bexar

Phase I

Contract Number: FA8649-21-P-1006
Start Date: 4/14/21    Completed: 7/14/21
Phase I year
2021
Phase I Amount
$49,648
This Phase I Small Business Innovative Research (SBIR) project seeks to demonstrate the feasibility of an Artificial Intelligence (AI)-augmented Raman scanner, small and portable for the warfighter, that can rapidly detect, identify and differentiate viral and bacterial pathogens and their variants. The proposed device would protect warfighters and civilians alike in a wide range of challenging field environments. Current fieldable pathogen detection technologies: Have limited panels of biothreats for detection Are time-consuming because a sample needs to be tested individually for each biothreat of interest Have major issues with false negative/positive results and reagent stability Are expensive - consumables include swabs, reagents, and collection bags Do not support outbreak analytics and outbreak response The proposed solution leverages a Commercial Off-the-Shelf (COTS) Raman scanner, ruggedized and augmented by SBIR-derived AI innovations. The electronic detection method eliminates the need for expensive consumables that can range from $80 to $450 per analysis, enabling unlimited analysis at less than one cent per analysis. The proposed devices also will be networked and interoperable to support outbreak analytics and outbreak response.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----